An MF that has lost its footing in recent yrs

ET Wealth collaborates with Value Research to analyse top mutual funds. We examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision.How the fund has performed 80600646 80600651Where the fund invests 80600694Basic factsDate of launch: 9 August 2004Category: EquityType: Mid CapAUM*: Rs 6,182.90 crBenchmark: Nifty Midcap 100 Total Return IndexWhat it costsNAV**Growth Option: Rs 159.44Dividend: Rs 44.6Minimum Investment Rs 5,000Minimum SIP amount: Rs 500Expense Ratio***(%): 1.91For units in excess of 10% of the investment,1% will be charged for redemption*As on 31 Dec 2020***As on 31 Dec 2020**As on 25 Jan 2021Fund managers: Venugopal Manghat, Vihang NaikTenure: 1 Year, 4 Years & 6 MonthsTop 5 sectors in portfolio (%) 80600702Top 5 stocks in portfolio (%) 80600711Recent portfolio changesNew Entrants: NAComplete Exits: EIH, KPR Mills, Shree Cement, Techno Electric & Engineering Co (Dec).Additions: EIH, Pfizer (Oct)How risky is it? 80600720Should you buy?While this fund continues its mid-cap positioning, it has had to dial down its earlier sizeable small-cap exposure. It now retains only marginal presence in the segment. The fund portfolio is heavily diversified and its risk conscious approach is evident in the limited exposure taken to individual bets. The fund manager is comfortable taking sharp sector deviations relative to index -currently heavily overweight pharma and chemicals. A consistent outperfomer over many years, the fund has lost its footing in recent years. With its earlier long serving fund manager having moved on a year ago, the current team needs time to prove execution capabilities. Source: Value Research

from Economic Times https://ift.tt/2O35mx4